Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Rex is on the rebound, expanding geographic reach with Delta Air Lines

  • In News
  • May 2, 2022
  • Samantha Freidin
Rex is on the rebound, expanding geographic reach with Delta Air Lines

Airlines are examples of logistical excellence. There’s a mind boggling amount of operational planning cogs that need to turn to move people and their stuff to where it needs to go. Getting there on time and in one piece is one thing, maximising efficiencies for the airline is another. 

In an effort to improve their customer experience and increase efficiency, regional airline Rex (ASX: REX) has partnered with leading global airline Delta Air Lines (NYSE: DAL). As one of the world’s oldest airlines still in operation, Delta knows a thing or two about boosting efficiency having been recognised for their world class customer experience and operational reliability by J.D Power, Fortune’s World’s Most Admired Companies, the Wall Street Journal and Business Travel News.

The two carriers have signed a letter of intent to enter into a definitive commercial agreement which will see Delta and Rex provide ticketing and baggage services to one another, providing customers with a seamless connection experience. 

Delta operates over 4,000 flights per day to over 275 locations worldwide. One such route is their daily non-stop service from Sydney to Los Angeles. Delta is intent on increasing the route’s frequency to ten flights a week come December. Interline ticketing will allow travellers to fly regionally in Australia through Rex, and internationally through Delta, significantly expanding potential revenue and customer base.

Deputy Chairman of Rex, the Hon John Sharp AM is optimistic that the partnership will give a much needed boost to the post-COVID return of international travel. “Delta will not only connect international travellers on Rex’s trunk domestic routes, but could also allow them easy access to Rex’s expansive network of over 60 routes throughout regional Australia.” 

Delta’s Vice President – Alliance Partner Development, Jeff Arinder said: “Rex will be a valued partner that will bring additional connectivity and geographic reach to both airlines. We look forward to welcoming more customers to our flights from Sydney to the U.S and providing a world-class customer experience in the air and on the ground.” 

Reeling from the effects of COVID, Rex saw an operating loss of $27.4 million in FY20 and $18.4 million in FY21. The Company is on the rebound though, with customer numbers on the rise and passenger revenue up 60.5% to $68.7 million for the first half of 2022.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.